Viewing StudyNCT02154776



Ignite Creation Date: 2024-05-06 @ 2:55 AM
Last Modification Date: 2024-10-26 @ 11:25 AM
Study NCT ID: NCT02154776
Status: COMPLETED
Last Update Posted: 2020-12-19
First Post: 2014-05-28

Brief Title: Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR HER2-negative Post-menopausal Women With Advanced Breast Cancer
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-06-27
Start Date Type: ACTUAL
Primary Completion Date: 2016-10-26
Primary Completion Date Type: ACTUAL
Completion Date: 2016-10-26
Completion Date Type: ACTUAL
First Submit Date: 2014-05-28
First Submit QC Date: May 30 2014
Study First Post Date: 2014-06-03
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-12-16
Last Update Post Date: 2020-12-19
Last Update Post Date Type: ACTUAL